EFNB2 and cancer: Furthermore, treatment of OSCC cells with an ephrin-B2 ligand, the Eph-B4-Fc chimera, did not influence these processes, suggesting that the cancer-promoting effect of endogenous ephrin-B2 was independent of its binding with eph-B4 expressed in neighboring cells.